Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000018.xml
Facial Plast Surg 2004; 20(2): 117-123
DOI: 10.1055/s-2004-861751
DOI: 10.1055/s-2004-861751
Collagen Fillers in Facial Aesthetic Surgery
Further Information
Publication History
Publication Date:
11 January 2005 (online)

ABSTRACT
The search for an ideal facial augmentation agent continues. Patient evaluation, choice of augmentation agent, and injection technique are discussed.
KEYWORDS
Collagen - rhytids - hyaluronic acid
REFERENCES
- 1 Skouge J, Diwan R. Soft tissue augmentation with injectable collagen. In: Papel I, Nachlas N Facial Plastic and Reconstructive Surgery St Louis; Mosby Year Book 1992: 203-212
- 2 Clark D P, Hanke C W, Swanson N A. Dermal implants: safety of products injected for soft tissue augmentation. J Am Acad Dermatol. 1989; 21(5 Pt 1) 992-998
- 3 Burgess L P, Goode R L. Injectable collagen. Facial Plast Surg. 1992; 8 176-182
- 4 Pollack S V. Silicone, fibrel, and collagen implantation for facial lines and wrinkles. J Dermatol Surg Oncol. 1990; 16 957-961
- 5 DeLustro F, Smith S T, Sundsmo J et al.. Reaction to injectionable collagen: results in animal models and clinical use. Plast Reconstr Surg. 1987; 4 581-589
- 6 Fagien S. Facial soft-tissue augmentation with injectable autologous and allogeneic human tissue collagen matrix (autologen and dermalogen). Plast Reconstr Surg 2000 105: 362-373 (discussion 74-75)
- 7 Sclafani A P, Romo III T, Parker A et al.. Autologous collagen dispersion (Autologen) as a dermal filler: clinical observations and histologic findings. Arch Facial Plast Surg. 2000; 2 48-52
- 8 Engstrom-Laurent A. Hyaluronan in joint disease. J Intern Med. 1997; 242 57-60
- 9 Lee J Y, Spicer A P. Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr Opin Cell Biol. 2000; 12 581-586
- 10 Sutherland I W. Novel and established applications of microbial polysaccharides. Trends Biotechnol. 1998; 16 41-46
- 11 Laurent T C, Fraser J R. Hyaluronan. FASEB J. 1992; 6 2397-2404
- 12 Goa K L, Benfield P. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs. 1994; 47 536-566
- 13 Kumari K, Weigel P H. Molecular cloning, expression, and characterization of the authentic hyaluronan synthase from group C Streptococcus equisimilis. J Biol Chem. 1997; 272 32539-32546
- 14 Piacquadio D. Crosslinked hyaluronic acid (hylan gel) as a soft tissue augmentation material: a preliminary assessment. In: Elson M Evaluation and Treatment of the Aging Face New York; Springer-Verlag 1994: 174-178
- 15 Piacquadio D, Jarcho M, Goltz R. Evaluation of hylan b gel as a soft-tissue augmentation implant material. J Am Acad Dermatol. 1997; 36 544-549
- 16 Olenius M. The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles, and folds. Aesthetic Plast Surg. 1998; 22 97-101
- 17 Duranti F, Salti G, Bovani B et al.. Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study. Dermatol Surg. 1998; 24 1317-1325
- 18 Lowe N J, Maxwell C A, Lowe P et al.. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol. 2001; 45 930-933
- 19 Micheels P. Human anti-hyaluronic acid antibodies: is it possible?. Dermatol Surg. 2001; 27 185-191
- 20 Shafir R, Amir A, Gur E. Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast Reconstr Surg. 2000; 106 1215-1216
- 21 Kavouni A, Stanec J J. Human antihyaluronic acid antibodies. Dermatol Surg. 2002; 28 359-360
- 22 Lupton J R, Alster T S. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg. 2000; 26 135-137
- 23 Schanz S, Schippert W, Ulmer A et al.. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol. 2002; 146 928-929
- 24 Friedman P M, Mafong E A, Kauvar A N, Geronemus R G. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg. 2002; 28 491-494
- 25 Larsen N E, Pollak C T, Reiner K et al.. Hylan gel biomaterial: dermal and immunologic compatibility. J Biomed Mater Res. 1993; 27 1129-1134
- 26 Manna F, Dentini M, Desideri P et al.. Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (hylaform from rooster combs and restylane from streptococcus) used for soft tissue augmentation. J Eur Acad Dermatol Venereol. 1999; 13 183-192
- 27 Filion M C, Phillips N C. Pro-inflammatory activity of contaminating DNA in hyaluronic acid preparations. J Pharm Pharmacol. 2001; 53 555-561
- 28 Bergeret-Galley C, Latouche X, Illouz Y G. The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep. Aesthetic Plast Surg. 2001; 25 249-255
Raymond S DouglasM.D.
Shorr-Douglas FACE Institute, 435 N. Roxbury
Suite 104, Beverly Hills, CA 90210